We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-12.49%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$48.6B
AUM Growth
-$4.2B
Cap. Flow
+$3.6B
Cap. Flow %
7.4%
Top 10 Hldgs %
10.29%
Holding
4,108
New
835
Increased
964
Reduced
740
Closed
743

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$340M
2
BAC icon
Bank of America
BAC
+$302M
3
CI icon
Cigna
CI
+$294M
4
TSM icon
TSMC
TSM
+$275M
5
UNP icon
Union Pacific
UNP
+$256M

Top Sells

Rank Stock Value
1
VZ icon
Verizon
VZ
+$426M
2
SPGI icon
S&P Global
SPGI
+$413M
3
BKNG icon
Booking.com
BKNG
+$264M
4
CMCSA icon
Comcast
CMCSA
+$256M
5
TFX icon
Teleflex
TFX
+$241M

Sector Composition

Rank Sector Weight
1 Healthcare 17.59%
2 Financials 16.96%
3 Technology 16.37%
4 Consumer Discretionary 9.33%
5 Industrials 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OACB.WS
4026
CALL
DELISTED
Oaktree Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share
OACB.WS
-93,542
Closed -$930K
TCAC
4027
DELISTED
Tuatara Capital Acquisition Corporation Class A Ordinary Shares
TCAC
-872,560
Closed -$8.63M
GLAQW
4028
CALL
DELISTED
Globis Acquisition Corp. Warrant
GLAQW
-517,106
Closed -$5.29M
TACA.WS
4029
CALL
DELISTED
Trepont Acquisition Corp I Redeemable Warrants, each whole warrant exercisable for one Class A ordin
TACA.WS
-378,637
Closed -$3.8M
TACA
4030
DELISTED
Trepont Acquisition Corp I
TACA
-595,209
Closed -$5.98M
CERN
4031
DELISTED
Cerner Corp
CERN
-661,285
Closed -$61.9M
CAS.WS
4032
CALL
DELISTED
Cascade Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class
CAS.WS
-299,996
Closed -$3.02M
CAS
4033
DELISTED
Cascade Acquisition Corp.
CAS
-997,970
Closed -$10.1M
TSC
4034
DELISTED
TriState Capital Holdings, Inc.
TSC
-32,494
Closed -$1.08M
OCA.WS
4035
CALL
DELISTED
Omnichannel Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A comm
OCA.WS
-392,407
Closed -$3.91M
OCA
4036
DELISTED
Omnichannel Acquisition Corp.
OCA
-780,845
Closed -$7.79M
OCDX
4037
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
-92,388
Closed -$1.73M
IIN
4038
DELISTED
IntriCon Corporation
IIN
-36,602
Closed -$872K
ATRS
4039
DELISTED
Antares Pharma, Inc.
ATRS
-275,284
Closed -$1.13M
ZNGA
4040
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
-880,890
Closed -$8.14M
MIME
4041
DELISTED
Mimecast Limited
MIME
-40,135
Closed -$3.19M
ARTA
4042
DELISTED
Artisan Acquisition Corp. Class A Ordinary Shares
ARTA
-1,368,541
Closed -$13.5M
ARTAW
4043
CALL
DELISTED
Artisan Acquisition Corp. Warrants
ARTAW
-320,000
Closed -$3.16M
XENT
4044
DELISTED
Intersect ENT, Inc
XENT
-121,032
Closed -$3.39M
EPAY
4045
DELISTED
Bottomline Technologies Inc
EPAY
-52,145
Closed -$2.96M
JOBS
4046
DELISTED
51job Inc
JOBS
-382,308
Closed -$22.4M
BRCC.WS
4047
CALL
DELISTED
BRC Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock a
BRCC.WS
-300,000
Closed -$6.26M
MACUW
4048
CALL
DELISTED
Mallard Acquisition Corp. Warrant
MACUW
-393,190
Closed -$3.96M
MGP
4049
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
-40,917
Closed -$1.58M
ATSPT
4050
DELISTED
Archimedes Tech SPAC Partners Co. Subunit
ATSPT
-528,138
Closed -$5.25M

Similar funds

Marshall Wace's Q2 2022 Portfolio in Review

As of Q2 2022, Marshall Wace held 4,108 positions worth $48.6B, down 8% from $52.8B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Marshall Wace deployed $3.6B of net new capital in Q2 2022, opening 835 new positions and adding to 964 existing holdings. Its largest new stake was Eli Lilly: 1,133,393 shares worth $367M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Verizon, an estimated $426M trimmed.

  • Marshall Wace's largest Q2 2022 buy was Eli Lilly: 1,133,393 shares worth $367M.
  • Marshall Wace added most to Bank of America in Q2 2022, an estimated $302M increase.
  • Marshall Wace's biggest Q2 2022 reduction was Verizon, cutting an estimated $426M.
  • Marshall Wace fully exited Teleflex in Q2 2022, selling an estimated $241M.
  • Marshall Wace's ten largest holdings make up 10% of its $48.6B portfolio in Q2 2022.
  • Marshall Wace opened 835 new positions and closed 743 in Q2 2022.
  • Marshall Wace's portfolio value fell 8% quarter-over-quarter to $48.6B.

Based on Marshall Wace's 13F filing for Q2 2022, filed 15 Aug 2022.